Evidence map›Paper›PMID 41353271›Full record

ArticleScientific reports2025

Discriminative biomarker selection using hybrid multi-population evolutionary computation.

Alok Kumar Shukla, Shubhra Dwivedi, Aishwarya Mishra

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alok Kumar ShuklaThapar Institute of Engineering & Technology, Patiala, Punjab, India.
Shubhra DwivediThapar Institute of Engineering & Technology, Patiala, Punjab, India.
Aishwarya MishraManipal University Jaipur, Jaipur, Rajasthan, India. aishwarya.mishra@jaipur.manipal.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid advancement of Deoxyribonucleic acid (DNA) sequencing technology has gained more attention, especially in interpreting high-dimensional, low-sample-size microarray data for disease identification. However, conventional gene selection techniques struggle to identify optimal biomarker subsets from gene data within a feasible time. To address this, we propose a novel hybrid method for robust cancer classification and biomarker discovery. To reduce the dimensionality of gene data while preserving biologically meaningful patterns, in the first stage of our approach, Kernel Principal Component Analysis (KPCA) is utilized. The refined gene subsets are then processed by the Multi-Population Gravitational Search Algorithm (GSA) known as MPKGSA with Opposition-Based Learning (OBL). The hybridization mechanism involves using OBL to generate a set of opposite solutions for each population, which is then integrated into the GSA update process. This process provides a more diverse exploration of the search space, preventing premature convergence on suboptimal gene subsets. The effectiveness of MPKGSA was evaluated on six microarray cancer datasets and a breast cancer single-nucleotide polymorphism (SNP) dataset from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO). Numerical results demonstrate that MPKGSA excels at balancing convergence and diversity, achieving high prediction accuracy with minimal biomarker subsets. Furthermore, it outperformed existing meta-heuristic methods, selecting a small number of gene biomarkers strongly correlated with the biological response class, confirming its utility for precise cancer identification and classification.

Indexed as

Biomarkers, TumorComputational BiologyNeoplasmsAlgorithmsBreast NeoplasmsFemaleGene Expression ProfilingHumansPolymorphism, Single NucleotidePrincipal Component AnalysisBiomarkers, TumorConvolution neural networkDeep neural networkIntrusion detectionLong short-term memoryMinimum redundancy maximum relevance

Identifiers

PMID41353271
PMCPMC12775414

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.